Altimmune, Inc.·4

Mar 24, 8:54 PM ET

Eisenstadt Richard I 4

4 · Altimmune, Inc. · Filed Mar 24, 2023

Insider Transaction Report

Form 4
Period: 2023-03-24
Eisenstadt Richard I
Chief Financial Officer
Transactions
  • Purchase

    Common Stock, par value $0.0001

    2023-03-24$4.31/sh+10,000$43,14022,010 total

Documents

1 file
  • 4
    tm2310588d1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT